Literature DB >> 3111259

Respiratory muscle weakness and ventilatory failure in AL amyloidosis with muscular pseudohypertrophy.

R M Santiago, D Scharnhorst, G Ratkin, E C Crouch.   

Abstract

Generalized muscle weakness culminating in ventilatory failure developed in a 59-year-old man with kappa light chain multiple myeloma. Physical examination demonstrated skeletal muscle enlargement, severe proximal muscle weakness, and macroglossia, consistent with amyloid-associated muscle pseudohypertrophy. Pulmonary function studies revealed a severe restrictive abnormality with a low maximal inspiratory pressure and maximal voluntary ventilation. Arterial blood gas values and chest radiographic results were normal. There was no clinical evidence of cardiac or central nervous system disease. At autopsy, skeletal muscles and diaphragm were diffusely infiltrated by amyloid. There was also multifocal deposition of amyloid in alveolar septae, esophagus, and subendocardium. This report suggests that ventilatory failure may occur as a complication of myeloma-associated (AL) amyloidosis involving the respiratory muscles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111259     DOI: 10.1016/0002-9343(87)90516-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Myopathy in primary systemic amyloidosis.

Authors:  M A Gertz; R A Kyle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

2.  Amyloid myopathy presenting with respiratory failure.

Authors:  J Ashe; C O Borel; G Hart; R L Humphrey; D A Derrick; R W Kuncl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

3.  Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of Literature.

Authors:  Aleksey Novikov; Horatio Holzer; Robert A DeSimone; Ghaith Abu-Zeinah; David J Pisapia; Tomer M Mark; Raymond D Pastore
Journal:  Case Rep Oncol Med       Date:  2015-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.